Description
IGF::CT::IGF BLOOD SERVICES AND PRODUCTS
First action · last action
2016-06-02 · 2016-10-17
Transactions
2
First transaction's obligation
$60,000
Base + all options value (sum of deltas)
$65,955
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA26315D0072
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2016-06-02+$60,000= $60,000
- Mod P000012016-10-17+$5,955= $65,955
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2016-06-02 | +$60,000 | $60,000 | IGF::CT::IGF BLOOD SERVICES AND PRODUCTS |
| Mod P00001· CLOSE OUT | 2016-10-17 | +$5,955 | $65,955 | IGF::CT::IGF BLOOD SERVICES AND PRODUCTS |
Related awards · 10
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CFN4PQKSBV56)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26326N0219 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $317,178 | FY2026 |
| 36C26326D0013 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C25226N0070 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C25225N0050 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $330 | FY2025 |
| 36C26325N0085 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $225,725 | FY2025 |
| 36C25224N0030 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $1,253 | FY2024 |
Other recipients under Q999 from 437-FARGO VA MEDICAL CENTER (00437) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA26316J0162 | SANFORD MEDICAL CENTER | 437-FARGO VA MEDICAL CENTER (00437) | $82,397 | FY2016 |
| VA26315J0896 | VITALANT | 437-FARGO VA MEDICAL CENTER (00437) | $67,507 | FY2016 |
| VA26315J0247 | SANFORD MEDICAL CENTER | 437-FARGO VA MEDICAL CENTER (00437) | $100,325 | FY2015 |
| VA26315D0007 | SANFORD MEDICAL CENTER | 437-FARGO VA MEDICAL CENTER (00437) | $0 | FY2015 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26316J0476_3600_VA26315D0072_3600 · retrieved 2026-09-26.